Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-022767
Form type
SC 13G
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Feb 14, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub